EV/EBITDA:
-3.31-0.05(-1.53%)Summary
- As of today (July 4, 2025), RXRX EV/EBITDA is -3.31, with a fall of -0.05 (-1.53%) during the most recent trading session on July 3, 2025.
- Over the past year, RXRX EV/EBITDA has increased by +1.51 (+31.33%).
- RXRX EV/EBITDA is now -69.74% below its all-time high of -1.95.
Performance
RXRX EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
RXRX EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | -1.5% | +1.4% | +1.1% |
| 1 m1 month | -26.3% | +26.0% | +20.1% |
| 3 m3 months | -12.6% | +12.3% | +9.6% |
| 6 m6 months | +45.8% | -33.5% | -32.4% |
| ytdytd | +35.6% | -20.9% | -22.0% |
| 1 y1 year | +31.3% | +3.3% | -28.3% |
| 5 y5 years | - | - | - |
RXRX EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -2.62 | -26.3% | -3.48 | +4.9% |
| 3 m | 3-month | -2.29 | -44.5% | -3.75 | +11.7% |
| 6 m | 6-month | -2.29 | -44.5% | -9.10 | +63.6% |
| 1 y | 1-year | -2.29 | -44.5% | -9.10 | +63.6% |
| 3 y | 3-year | -1.95 | -69.7% | -11.41 | +71.0% |
| 5 y | 5-year | -1.95 | -69.7% | -65.18 | +94.9% |
| alltime | all time | -1.95 | -69.7% | -65.18 | +94.9% |
RXRX EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -3.31(-35.6%) |
| 2024 | -5.14(-18.3%) |
| Date | Value |
|---|---|
| 2023 | -6.29(+53.4%) |
| 2022 | -4.10(-72.8%) |
| 2021 | -15.09 |
FAQ
- What is Recursion Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Recursion Pharmaceuticals?
- What is RXRX EV/EBITDA year-to-date change?
- What is Recursion Pharmaceuticals EV/EBITDA year-on-year change?
What is Recursion Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of RXRX is -3.31
What is the all time high EV/EBITDA for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high EV/EBITDA is -1.95
What is RXRX EV/EBITDA year-to-date change?
Recursion Pharmaceuticals EV/EBITDA has changed by +1.83 (+35.60%) since the beginning of the year
What is Recursion Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, RXRX EV/EBITDA has changed by +1.51 (+31.33%)